Sucampo Pharmaceuticals, Inc. (SCMP) Tops Q2 EPS by 1c; Updates FY14 GAAP EPS Outlook
Tweet
Share
E-mailGet Alerts SCMP Hot Sheet
Price: $18.00 --0%
Financial Fact:
Selling and marketing: 696K
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Selling and marketing: 696K
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) reported Q2 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $24.1 million versus the consensus estimate of $24.06 million.
Sucampo Pharmaceuticals, Inc. sees FY2014 EPS of $0.08-$0.13, versus the consensus of $0.18.
For earnings history and earnings-related data on Sucampo Pharmaceuticals, Inc. (SCMP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Stardust Power (SDST) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
